NITROFINN® – Important additional strenght to Innventa portfolio
After launching of Serapinn forte®, Forticolinn®, Miocytinn®, Laringinn® and Rhinosinn®, Innventa is continuing with fulfillment of ambitious 2018 new products launch plan. On 20th of July 2018 in Serbian pharmacies is available new product in Innventa urology portfolio – Nitrofinn®.
Nitrofinn® is currently the only registered Nitrofurantoin on the market, keeping Innventa faitfull to it’s mission: providing inventive pharma solutions to health sector.
Goran Orlic, the general menager of Innventa, stated that introduction of Nitrofinn® represents important milestone in further strong growth in Innventa sales in Serbia and region.